← Eichor
Study identifier: NCT05428358 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery

Condition: Pancreatic Cancer · Pancreatic Neoplasm · Liver Metastases  ·  Sponsor: University of Aarhus

PhaseNA
Planned participants200
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

The aim of the study is to examine the incremental value of using magnetic resonance imaging (MRI) in addition to computed tomography (CT) in the diagnostic workup of pancreatic cancer patients.

This description comes directly from the study's public registry record.

Talk to the study team

Jakob Kirkegård, MD, PhD  ·  +4522900604  ·  jakob.kirkegaard@auh.rm.dk

Frank Mortensen, MD, DMSc  ·  +45222517296  ·  frmort@rm.dk

Always discuss trial participation with your own doctor first.

Locations (3)

Aalborg University HospitalAalborg, DenmarkRecruiting
Aarhus University HospitalAarhus, DenmarkRecruiting
RigshospitaletCopenhagen, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05428358